Article Text
Treatment
Losartan reduced stroke and new onset diabetes more than atenolol in essential hypertension with signs of left ventricular hypertrophy
Statistics from Altmetric.com
Footnotes
Source of funding: Merck.
For correspondence: Professor B Dahlöf, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden. bdahlof{at}scandinaviancri.se
A modified version of this abstract appears in ACP Journal Club.